首页 > 最新文献

中华男科学杂志最新文献

英文 中文
[Dietary intervention to improve erectile dysfunction: Progress in research]. 饮食干预改善勃起功能障碍:研究进展
Q4 Medicine Pub Date : 2025-09-01
Wen-Li Liu, Jing Xu, Hai-Liang DU, Wen-Jin Zhang

This review focuses on the mechanisms of dietary intervention improving ED, dietary intervention modalities, and dietary recommendations, aiming to provide some guidance to ED patients in developing healthy dietary habits, so as to prevent and improve ED and promote overall health.

本文就饮食干预改善ED的机制、饮食干预方式、饮食建议等方面进行综述,旨在指导ED患者养成健康的饮食习惯,从而预防和改善ED,促进整体健康。
{"title":"[Dietary intervention to improve erectile dysfunction: Progress in research].","authors":"Wen-Li Liu, Jing Xu, Hai-Liang DU, Wen-Jin Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This review focuses on the mechanisms of dietary intervention improving ED, dietary intervention modalities, and dietary recommendations, aiming to provide some guidance to ED patients in developing healthy dietary habits, so as to prevent and improve ED and promote overall health.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"841-845"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[RNA-binding protein ELAVL1 regulates SOX4 stability and promotes hormone-sensitive prostate cancer proliferation through m6A-dependent regulation]. [rna结合蛋白ELAVL1通过m6a依赖性调控SOX4稳定性,促进激素敏感性前列腺癌增殖]。
Q4 Medicine Pub Date : 2025-09-01
Sha-Sha Min, Zhong-Lin Cai, Yan-Ting Shen, Zhong Wang
<p><strong>Objective: </strong>To investigate the expression of RNA binding protein ELAVL1 in prostate cancer (PCa), especially hormone-sensitive prostate cancer (HSPC), and its relationship with tumor proliferation. This study further aims to reveal the molecular mechanism by which ELAVL1 promotes HSPC proliferation by stabilizing SOX4 mRNA in an m6A-dependent manner.</p><p><strong>Methods: </strong>The expression of ELAVL1 in PCa tissues and its relationship with prognosis were analyzed in the Cancer Genome Atlas (TCGA) database, and the differences in HSPC and hormone-resistant prostate cancer (HRPC) were compared. And its relationship with prognosis were analyzed in the Cancer Genome Atlas (TCGA) database, and the differences in HSPC and hormone-resistant prostate cancer (HRPC) were compared. Western blot was used to detect ELAVL1 protein expression in PCa cell lines. After ELAVL1 knockdown by siRNA, cell proliferation was evaluated using CCK-8 assays, and changes in downstream target genes were detected by RT-qPCR. Tumor xenograft experiments in nude mice were performed to further assess the impact of ELAVL1 on tumor growth. The interaction between ELAVL1 and SOX4 mRNA was verified by RIP-seq. And the mRNA and protein levels of SOX4 after knockdown of ELAVL1 were detected by RT-qPCR and Western blot, respectively. CCK-8 was used to evaluate the effect of SOX4 knockdown on cell proliferation. MeRIP-qPCR was used to detect the m6A modification level of SOX4 and the effect of knocking down METTL3. RNA pull-down experiments verified the interaction between SOX4 RNA fragments and ELAVL1 protein. RNA stability experiments evaluated the effect of ELAVL1 knockdown on SOX4 mRNA stability.</p><p><strong>Results: </strong>The expression of ELAVL1 in PCa cells was higher than that in normal prostate epithelial cells. The prognosis of patients with high expression of ELAVL1 was significantly worse than that of patients with low expression. In the GSE32269 dataset, the expression level of ELAVL1 in HSPC was significantly higher than that in HRPC. After knocking down of ELAVL1 in LNCaP and VCaP cells, CCK-8 experiments showed that the cell proliferation ability was significantly affected after knocking down ELAVL1, and overexpressed ELAVL1 promoted the proliferation of HSPC cells. The results of in vivo studies showed that knockdown of ELAVL1 significantly inhibited the tumorigenic capacity of LNCaP cells and resulted in a marked reduction in xenograft tumor mass. The levels of SOX4 mRNA and protein in LNCaP and VCaP cells were significantly higher than those in normal prostate epithelial cells RWPE-1. RIP-qPCR confirmed the interaction between ELAVL1 protein and SOX4 mRNA. After knocking down of ELAVL1, the expression levels of SOX4 mRNA and protein were significantly decreased. After knocking down of SOX4, the proliferation ability of LNCaP and VCaP cells was significantly inhibited.</p><p><strong>Conclusion: </strong>ELAVL1 is highly expressed in HSPC.
目的:探讨RNA结合蛋白ELAVL1在前列腺癌(PCa)尤其是激素敏感性前列腺癌(HSPC)中的表达及其与肿瘤增殖的关系。本研究旨在进一步揭示ELAVL1通过m6a依赖的方式稳定SOX4 mRNA促进HSPC增殖的分子机制。方法:在癌症基因组图谱(Cancer Genome Atlas, TCGA)数据库中分析ELAVL1在前列腺癌组织中的表达及其与预后的关系,比较HSPC与激素抵抗性前列腺癌(hormone-resistant prostate Cancer, HRPC)的差异。在Cancer Genome Atlas (TCGA)数据库中分析其与预后的关系,并比较HSPC与激素抵抗性前列腺癌(HRPC)的差异。Western blot检测ELAVL1蛋白在PCa细胞系中的表达。siRNA敲低ELAVL1后,采用CCK-8检测细胞增殖,RT-qPCR检测下游靶基因的变化。裸鼠肿瘤异种移植实验进一步评估ELAVL1对肿瘤生长的影响。通过RIP-seq验证了ELAVL1和SOX4 mRNA之间的相互作用。RT-qPCR和Western blot分别检测ELAVL1敲低后SOX4 mRNA和蛋白水平。CCK-8检测SOX4敲除对细胞增殖的影响。采用MeRIP-qPCR检测SOX4基因m6A修饰水平及敲除METTL3的效果。RNA下拉实验证实了SOX4 RNA片段与ELAVL1蛋白的相互作用。RNA稳定性实验评估了ELAVL1敲低对SOX4 mRNA稳定性的影响。结果:ELAVL1在前列腺癌细胞中的表达高于正常前列腺上皮细胞。ELAVL1高表达患者的预后明显差于低表达患者。在GSE32269数据集中,ELAVL1在HSPC中的表达水平显著高于HRPC。在LNCaP和VCaP细胞中敲除ELAVL1后,CCK-8实验表明,敲除ELAVL1后,细胞增殖能力明显受到影响,过表达ELAVL1促进了HSPC细胞的增殖。体内研究结果表明,敲低ELAVL1显著抑制LNCaP细胞的致瘤能力,导致异种移植物肿瘤体积显著减少。LNCaP和VCaP细胞中SOX4 mRNA和蛋白表达水平显著高于正常前列腺上皮细胞RWPE-1。RIP-qPCR证实了ELAVL1蛋白与SOX4 mRNA的相互作用。敲除ELAVL1后,SOX4 mRNA和蛋白的表达水平显著降低。敲除SOX4后,LNCaP和VCaP细胞的增殖能力明显受到抑制。结论:ELAVL1在HSPC中高表达。ELAVL1的高表达与HSPC的增殖有关。SOX4是ELAVL1的下游分子,可促进HSPC的增殖。ELAVL1通过依赖m6a的机制增强SOX4 mRNA的稳定性。
{"title":"[RNA-binding protein ELAVL1 regulates SOX4 stability and promotes hormone-sensitive prostate cancer proliferation through m6A-dependent regulation].","authors":"Sha-Sha Min, Zhong-Lin Cai, Yan-Ting Shen, Zhong Wang","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the expression of RNA binding protein ELAVL1 in prostate cancer (PCa), especially hormone-sensitive prostate cancer (HSPC), and its relationship with tumor proliferation. This study further aims to reveal the molecular mechanism by which ELAVL1 promotes HSPC proliferation by stabilizing SOX4 mRNA in an m6A-dependent manner.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The expression of ELAVL1 in PCa tissues and its relationship with prognosis were analyzed in the Cancer Genome Atlas (TCGA) database, and the differences in HSPC and hormone-resistant prostate cancer (HRPC) were compared. And its relationship with prognosis were analyzed in the Cancer Genome Atlas (TCGA) database, and the differences in HSPC and hormone-resistant prostate cancer (HRPC) were compared. Western blot was used to detect ELAVL1 protein expression in PCa cell lines. After ELAVL1 knockdown by siRNA, cell proliferation was evaluated using CCK-8 assays, and changes in downstream target genes were detected by RT-qPCR. Tumor xenograft experiments in nude mice were performed to further assess the impact of ELAVL1 on tumor growth. The interaction between ELAVL1 and SOX4 mRNA was verified by RIP-seq. And the mRNA and protein levels of SOX4 after knockdown of ELAVL1 were detected by RT-qPCR and Western blot, respectively. CCK-8 was used to evaluate the effect of SOX4 knockdown on cell proliferation. MeRIP-qPCR was used to detect the m6A modification level of SOX4 and the effect of knocking down METTL3. RNA pull-down experiments verified the interaction between SOX4 RNA fragments and ELAVL1 protein. RNA stability experiments evaluated the effect of ELAVL1 knockdown on SOX4 mRNA stability.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The expression of ELAVL1 in PCa cells was higher than that in normal prostate epithelial cells. The prognosis of patients with high expression of ELAVL1 was significantly worse than that of patients with low expression. In the GSE32269 dataset, the expression level of ELAVL1 in HSPC was significantly higher than that in HRPC. After knocking down of ELAVL1 in LNCaP and VCaP cells, CCK-8 experiments showed that the cell proliferation ability was significantly affected after knocking down ELAVL1, and overexpressed ELAVL1 promoted the proliferation of HSPC cells. The results of in vivo studies showed that knockdown of ELAVL1 significantly inhibited the tumorigenic capacity of LNCaP cells and resulted in a marked reduction in xenograft tumor mass. The levels of SOX4 mRNA and protein in LNCaP and VCaP cells were significantly higher than those in normal prostate epithelial cells RWPE-1. RIP-qPCR confirmed the interaction between ELAVL1 protein and SOX4 mRNA. After knocking down of ELAVL1, the expression levels of SOX4 mRNA and protein were significantly decreased. After knocking down of SOX4, the proliferation ability of LNCaP and VCaP cells was significantly inhibited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;ELAVL1 is highly expressed in HSPC. ","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"791-799"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Influencing factors of lower urinary tract symptoms in patients after radical prostatectomy and nursing strategy]. 根治性前列腺切除术后患者下尿路症状的影响因素及护理策略
Q4 Medicine Pub Date : 2025-09-01
Na Yu, Song Xu, Hao-Wei He, Dian Fu, Tian-Yi Shen, Meng Zhang

Objective: This study aims to analyze the influence factors of lower urinary tract symptoms (LUTS) in patients receiving radical prostatectomy for prostate cancer, and to explore effective nursing strategy in order to provide a theoretical basis for improving the postoperative quality of life of patients.

Methods: A retrospective study was conducted on 103 elderly male patients who underwent radical prostatectomy for prostate cancer in the Department of Urology at General Hospital of Eastern Theater Command from August 2022 to August 2024. The patients were categorized into two groups based on whether LUTS occurred. Demographic and clinical characteristics, perioperative parameters, follow-up data, and participation in pelvic floor muscle training were analyzed to identify risk factors associated with postoperative LUTS.

Results: The incidence of postoperative LUTS in the patients with LUTS before the operation was significantly higher than that in the patients without LUTS before the operation (68.42% vs 32.61%, P=0.001). Additionally, the use of larger catheters (22F) was closely associated with an increased incidence of postoperative LUTS(P<0.01). Pelvic floor exercises demonstrated a significant protective effect, with patients who engaged in pelvic floor exercises exhibiting a lower incidence of postoperative LUTS (38.60% vs 60.87%, P=0.040). Regression analysis further revealed that pelvic floor exercises was the protective factor for postoperative LUTS (OR=0.215, 95%CI: 0.091-0.508, P<0.01).

Conclusion: Preoperative LUTS and catheter size are significant risk factors for the occurrence of postoperative LUTS following radical prostatectomy. Pelvic floor muscle exercise after surgery has a protective effect. Postoperative personalized nursing interventions are necessary for different patients to achieve optimal recovery outcomes.

目的:本研究旨在分析前列腺癌根治性前列腺切除术患者下尿路症状(LUTS)的影响因素,探讨有效的护理策略,为提高患者术后生活质量提供理论依据。方法:回顾性分析2022年8月至2024年8月在东部战区总医院泌尿外科行根治性前列腺癌的老年男性患者103例。根据是否发生LUTS将患者分为两组。分析人口统计学和临床特征、围手术期参数、随访数据以及盆底肌肉训练的参与情况,以确定与术后LUTS相关的危险因素。结果:术前有LUTS的患者术后LUTS发生率明显高于术前无LUTS的患者(68.42% vs 32.61%, P=0.001)。此外,使用更大的导管(22F)与术后LUTS发生率增加密切相关(结论:术前LUTS和导管尺寸是根治性前列腺切除术后LUTS发生的重要危险因素。手术后进行盆底肌肉锻炼具有保护作用。为达到最佳的康复效果,术后个性化护理干预是必要的。
{"title":"[Influencing factors of lower urinary tract symptoms in patients after radical prostatectomy and nursing strategy].","authors":"Na Yu, Song Xu, Hao-Wei He, Dian Fu, Tian-Yi Shen, Meng Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to analyze the influence factors of lower urinary tract symptoms (LUTS) in patients receiving radical prostatectomy for prostate cancer, and to explore effective nursing strategy in order to provide a theoretical basis for improving the postoperative quality of life of patients.</p><p><strong>Methods: </strong>A retrospective study was conducted on 103 elderly male patients who underwent radical prostatectomy for prostate cancer in the Department of Urology at General Hospital of Eastern Theater Command from August 2022 to August 2024. The patients were categorized into two groups based on whether LUTS occurred. Demographic and clinical characteristics, perioperative parameters, follow-up data, and participation in pelvic floor muscle training were analyzed to identify risk factors associated with postoperative LUTS.</p><p><strong>Results: </strong>The incidence of postoperative LUTS in the patients with LUTS before the operation was significantly higher than that in the patients without LUTS before the operation (68.42% vs 32.61%, P=0.001). Additionally, the use of larger catheters (22F) was closely associated with an increased incidence of postoperative LUTS(P<0.01). Pelvic floor exercises demonstrated a significant protective effect, with patients who engaged in pelvic floor exercises exhibiting a lower incidence of postoperative LUTS (38.60% vs 60.87%, P=0.040). Regression analysis further revealed that pelvic floor exercises was the protective factor for postoperative LUTS (OR=0.215, 95%CI: 0.091-0.508, P<0.01).</p><p><strong>Conclusion: </strong>Preoperative LUTS and catheter size are significant risk factors for the occurrence of postoperative LUTS following radical prostatectomy. Pelvic floor muscle exercise after surgery has a protective effect. Postoperative personalized nursing interventions are necessary for different patients to achieve optimal recovery outcomes.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"818-822"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical effect of Huotujiji prescription on patients with asthenospermia of spleen-kidney yang-deficiency type]. [火土鸡肋方治疗脾肾阳虚型弱精子症的临床疗效]。
Q4 Medicine Pub Date : 2025-09-01
Yi-Li Cai, Hong-Ping Shen, Li Wang, Jia-Yi Song, Ya-Hua Liu, Yi Yu, Xue-Qin Chen

Objective: To observe the effectiveness and safety of Huotujiji prescription for patients with asthenospermia of spleen-kidney yang-deficiency.

Methods: Patients with spleen-kidney-yang deficiency type of asthenospermia were divided into two groups by randomized control method. The patients in the control group were treated with L-carnitine oral solution alone. And the patients in experimental group were treated with Huotujiji prescription. Semen volume, sperm concentration, PR, TCM symptom score and spouse pregnancy were compared between the two groups before and after treatment.

Results: A total of 115 patients were included in the study, with 55 in the experimental group and 60 in the control group. In the experimental group, the sperm concentration before and after treatment were (160.71±53.7)×106/mL, (187.19±41.89)×106/mL, and PR were (20.37±9.42)%, (26.7±6.92)%, respectively. PR+NP were (32.06±8.49)% and (34.89±7.25)%. After the treatment, the sperm motility of both groups significantly improved compared to pre-treatment levels (P<0.05). And the experimental group's sperm concentration also showed a significant increase after the treatment (P<0.05). The pregnancy rate of spouses in the control group was 11.67%, which was 29.09% in the experimental group. The pregnancy rate of the spouses in the two groups showed a statistically significant difference (P<0.05). After 12weeks of treatment, the Traditional Chinese Medicine (TCM) symptom scores in the control group did not decrease significantly compared to those before treatment (P> 0.05). In contrast, the TCM symptom scores in the experimental group decreased significantly after treatment (P<0.05). Moreover, compared with the control group, the TCM symptom scores of the experimental group decreased significantly after treatment (P<0.05).

Conclusion: Huotujiji prescription can safely and effectively improve the sperm quality and vitality of patients with spleen-kidney-yang deficiency type of asthenospermia, improve the symptoms of patients, and increase the pregnancy rate of their spouses, which is worthy of clinical promotion.

目的:观察火土鸡块方治疗脾肾阳虚型弱精子症的疗效和安全性。方法:采用随机对照法将弱精子症脾肾阳虚型患者分为两组。对照组患者单独给予左旋肉碱口服溶液治疗。试验组患者给予活土鸡肋方治疗。比较两组患者治疗前后精液量、精子浓度、PR、中医症状评分及配偶妊娠情况。结果:共纳入115例患者,实验组55例,对照组60例。实验组患者治疗前后精子浓度分别为(160.71±53.7)×106/mL、(187.19±41.89)×106/mL, PR分别为(20.37±9.42)%、(26.7±6.92)%。PR+NP分别为(32.06±8.49)%和(34.89±7.25)%。治疗后,两组精子活力均较治疗前显著提高(P < 0.05)。而实验组治疗后中医症状评分明显下降(p结论:活土集方能安全有效地改善脾肾阳虚型弱精子症患者的精子质量和活力,改善患者症状,提高其配偶的受孕率,值得临床推广。
{"title":"[Clinical effect of Huotujiji prescription on patients with asthenospermia of spleen-kidney yang-deficiency type].","authors":"Yi-Li Cai, Hong-Ping Shen, Li Wang, Jia-Yi Song, Ya-Hua Liu, Yi Yu, Xue-Qin Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To observe the effectiveness and safety of Huotujiji prescription for patients with asthenospermia of spleen-kidney yang-deficiency.</p><p><strong>Methods: </strong>Patients with spleen-kidney-yang deficiency type of asthenospermia were divided into two groups by randomized control method. The patients in the control group were treated with L-carnitine oral solution alone. And the patients in experimental group were treated with Huotujiji prescription. Semen volume, sperm concentration, PR, TCM symptom score and spouse pregnancy were compared between the two groups before and after treatment.</p><p><strong>Results: </strong>A total of 115 patients were included in the study, with 55 in the experimental group and 60 in the control group. In the experimental group, the sperm concentration before and after treatment were (160.71±53.7)×106/mL, (187.19±41.89)×106/mL, and PR were (20.37±9.42)%, (26.7±6.92)%, respectively. PR+NP were (32.06±8.49)% and (34.89±7.25)%. After the treatment, the sperm motility of both groups significantly improved compared to pre-treatment levels (P<0.05). And the experimental group's sperm concentration also showed a significant increase after the treatment (P<0.05). The pregnancy rate of spouses in the control group was 11.67%, which was 29.09% in the experimental group. The pregnancy rate of the spouses in the two groups showed a statistically significant difference (P<0.05). After 12weeks of treatment, the Traditional Chinese Medicine (TCM) symptom scores in the control group did not decrease significantly compared to those before treatment (P> 0.05). In contrast, the TCM symptom scores in the experimental group decreased significantly after treatment (P<0.05). Moreover, compared with the control group, the TCM symptom scores of the experimental group decreased significantly after treatment (P<0.05).</p><p><strong>Conclusion: </strong>Huotujiji prescription can safely and effectively improve the sperm quality and vitality of patients with spleen-kidney-yang deficiency type of asthenospermia, improve the symptoms of patients, and increase the pregnancy rate of their spouses, which is worthy of clinical promotion.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"827-831"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of predictive nursing to the rehabilitation of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery]. 【以增强术后恢复为理念的预测性护理在前列腺内镜术后患者康复中的应用】。
Q4 Medicine Pub Date : 2025-09-01
Qian Meng, Lei Yu, Xin Wang, Meng-Ling Wu, Xiu-Qin Ye

Objective: To explore the efficacy of predictive nursing on the recovery of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery(ERAS).

Methods: A total of 82 patients with benign prostatic hyperplasia who underwent surgery from February 2022 to February 2023 were divided into control group (n=41) with traditional care and the observation group (n=41) with predictive care based on the difference in nursing methods. And the clinical data of the two groups were compared. Results: The observation group showed lower incidence rates than the control group for all individual complications (urinary tract infection [2.44% vs 4.88%], hemorrhage [2.44% vs 7.32%], bladder spasm [0% vs 4.88%], and hypostatic pneumonia [0% vs 2.44%]), though none reached statistical significance (P>0.05). However, the total complication rate was significantly lower in the observation group (4.88% vs 19.51%, P < 0.05). Notably,the observation group demonstrated significantly lower IPSS scores (5.49±1.53 vs 10.35±1.77, P<0.05) and shorter hospital stays ([5.26±0.38] d vs [9.95±0.84] d, P<0.05). Additionally, nursing satisfaction was markedly higher in the observation group (92.68% vs 78.95%, P<0.05).Conclusion: The application of ERAS -guided anticipatory nursing in postoperative rehabilitation for patients with benign prostatic hyperplasia can significantly improve quality of life, reduce complication rates, shorten hospital stays, and enhance patient satisfaction.

目的:探讨在ERAS (enhanced recovery after surgery)理念下,预测性护理对前列腺内镜术后患者康复的影响。方法:选取2022年2月~ 2023年2月行手术治疗的良性前列腺增生患者82例,根据护理方法差异分为传统护理对照组(n=41)和预测护理观察组(n=41)。比较两组患者的临床资料。结果:观察组患者各单项并发症发生率(尿路感染[2.44%比4.88%]、出血[2.44%比7.32%]、膀胱痉挛[0%比4.88%]、肺源性肺炎[0%比2.44%])均低于对照组,但差异均无统计学意义(P < 0.05)。观察组总并发症发生率明显低于对照组(4.88% vs 19.51%, P < 0.05)。观察组患者IPSS评分显著低于对照组(5.49±1.53 vs 10.35±1.77,P < 0.05)
{"title":"[Application of predictive nursing to the rehabilitation of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery].","authors":"Qian Meng, Lei Yu, Xin Wang, Meng-Ling Wu, Xiu-Qin Ye","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the efficacy of predictive nursing on the recovery of patients after endoscopic surgery for prostate under the concept of enhanced recovery after surgery(ERAS).</p><p><strong>Methods: </strong>A total of 82 patients with benign prostatic hyperplasia who underwent surgery from February 2022 to February 2023 were divided into control group (n=41) with traditional care and the observation group (n=41) with predictive care based on the difference in nursing methods. And the clinical data of the two groups were compared. Results: The observation group showed lower incidence rates than the control group for all individual complications (urinary tract infection [2.44% vs 4.88%], hemorrhage [2.44% vs 7.32%], bladder spasm [0% vs 4.88%], and hypostatic pneumonia [0% vs 2.44%]), though none reached statistical significance (P>0.05). However, the total complication rate was significantly lower in the observation group (4.88% vs 19.51%, P < 0.05). Notably,the observation group demonstrated significantly lower IPSS scores (5.49±1.53 vs 10.35±1.77, P<0.05) and shorter hospital stays ([5.26±0.38] d vs [9.95±0.84] d, P<0.05). Additionally, nursing satisfaction was markedly higher in the observation group (92.68% vs 78.95%, P<0.05).Conclusion: The application of ERAS -guided anticipatory nursing in postoperative rehabilitation for patients with benign prostatic hyperplasia can significantly improve quality of life, reduce complication rates, shorten hospital stays, and enhance patient satisfaction.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"823-826"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Predictive efficacy of serum hepcidin, ferritin, and q-Dioxn MRI for upgrading, upstaging, and biochemical recurrence in prostate cancer patients: A comparative study]. [血清hepcidin、铁蛋白和q-Dioxn MRI对前列腺癌患者升级、分期和生化复发的预测作用:一项比较研究]。
Q4 Medicine Pub Date : 2025-09-01
Zhen Tian, Guang-Zheng Li, Ren-Peng Huang, Si-Yu Wang, Li-Chen Jin, Yu-Xin Lin, Yu-Hua Huang

Objective: The aim of this study is to explore the correlation among serum hepcidin, ferritin, and q-Dioxn MRI with upgrading, upstaging and biochemical recurrence in prostate cancer (PCa) patients.

Methods: A total of 103 PCa patients diagnosed by biopsy were selected for this study. All patients underwent q-Dixon MRI prior to biopsy for T2* value measurement. Then serum hepcidin and ferritin were measured before receiving radical prostatectomy. Pathological grading and staging were conducted both preoperatively and postoperatively. The correlations among hepcidin, ferritin, T2* values, and postoperative upgrading, upstaging, biochemical recurrence were subsequently analyzed.

Results: The hepcidin level of PCa patients was measured at (123.51 ± 23.03) ng/mL, while the ferritin level was recorded at (239.80 ± 79.59) ng/mL, and the T2* value was (41.07 ± 6.37) ms. A total of 49 and 36 cases were observed with upgrading and upstaging in postoperative pathology, respectively. The median follow-up duration was 28.0 months (6.0-38.0 months), during which biochemical recurrence was observed in 12 cases. For upgrading, hepcidin and ferritin demonstrated the predictive efficacy, with areas under the ROC curve of 0.777 and 0.642, respectively, whereas T2* values did not show sufficient predictive power. For upstaging, hepcidin, ferritin, and T2* exhibited predictive efficacy, with areas under the ROC curve of 0.806, 0.696, and 0.655, respectively. Multivariate Logistic regression analysis indicated that hepcidin served as an independent risk factor for both upgrading (OR 1.055, 95%CI 1.027-1.085, P<0.001) and upstaging (OR 1.094, 95%CI 1.040-1.152, P<0.001). Cox regression analysis showed that hepcidin (95%CI 1.000-1.052, P = 0.049) was a significant risk factor for predicting biochemical recurrence.

Conclusion: Hepcidin could serve as a predictor for pathological upgrading, upstaging and biochemical recurrence after radical prostatectomy, which provides a novel potential index for risk stratification and prognostic evaluation of PCa patients.

目的:探讨血清hepcidin、铁蛋白、q-Dioxn MRI与前列腺癌(PCa)患者升级、分期及生化复发的相关性。方法:选取103例活检确诊的前列腺癌患者作为研究对象。所有患者在活检前均行q-Dixon MRI测量T2*值。行根治性前列腺切除术前测定血清hepcidin和铁蛋白水平。术前、术后均进行病理分级和分期。分析hepcidin、铁蛋白、T2*值与术后升级、上分期、生化复发的相关性。结果:PCa患者hepcidin水平为(123.51±23.03)ng/mL,铁蛋白水平为(239.80±79.59)ng/mL, T2*值为(41.07±6.37)ms,术后病理升级和上分期分别为49例和36例。中位随访时间28.0个月(6.0 ~ 38.0个月),随访期间12例出现生化复发。对于升级,hepcidin和铁蛋白显示出预测效果,ROC曲线下面积分别为0.777和0.642,而T2*值没有足够的预测能力。对于前分期,hepcidin、铁蛋白和T2*具有预测作用,ROC曲线下面积分别为0.806、0.696和0.655。多因素Logistic回归分析显示,hepcidin是前列腺癌升级的独立危险因素(OR 1.055, 95%CI 1.027-1.085, p)。结论:hepcidin可作为前列腺根治术后病理升级、上分期和生化复发的预测因子,为前列腺癌患者的风险分层和预后评估提供了新的潜在指标。
{"title":"[Predictive efficacy of serum hepcidin, ferritin, and q-Dioxn MRI for upgrading, upstaging, and biochemical recurrence in prostate cancer patients: A comparative study].","authors":"Zhen Tian, Guang-Zheng Li, Ren-Peng Huang, Si-Yu Wang, Li-Chen Jin, Yu-Xin Lin, Yu-Hua Huang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to explore the correlation among serum hepcidin, ferritin, and q-Dioxn MRI with upgrading, upstaging and biochemical recurrence in prostate cancer (PCa) patients.</p><p><strong>Methods: </strong>A total of 103 PCa patients diagnosed by biopsy were selected for this study. All patients underwent q-Dixon MRI prior to biopsy for T2* value measurement. Then serum hepcidin and ferritin were measured before receiving radical prostatectomy. Pathological grading and staging were conducted both preoperatively and postoperatively. The correlations among hepcidin, ferritin, T2* values, and postoperative upgrading, upstaging, biochemical recurrence were subsequently analyzed.</p><p><strong>Results: </strong>The hepcidin level of PCa patients was measured at (123.51 ± 23.03) ng/mL, while the ferritin level was recorded at (239.80 ± 79.59) ng/mL, and the T2* value was (41.07 ± 6.37) ms. A total of 49 and 36 cases were observed with upgrading and upstaging in postoperative pathology, respectively. The median follow-up duration was 28.0 months (6.0-38.0 months), during which biochemical recurrence was observed in 12 cases. For upgrading, hepcidin and ferritin demonstrated the predictive efficacy, with areas under the ROC curve of 0.777 and 0.642, respectively, whereas T2* values did not show sufficient predictive power. For upstaging, hepcidin, ferritin, and T2* exhibited predictive efficacy, with areas under the ROC curve of 0.806, 0.696, and 0.655, respectively. Multivariate Logistic regression analysis indicated that hepcidin served as an independent risk factor for both upgrading (OR 1.055, 95%CI 1.027-1.085, P<0.001) and upstaging (OR 1.094, 95%CI 1.040-1.152, P<0.001). Cox regression analysis showed that hepcidin (95%CI 1.000-1.052, P = 0.049) was a significant risk factor for predicting biochemical recurrence.</p><p><strong>Conclusion: </strong>Hepcidin could serve as a predictor for pathological upgrading, upstaging and biochemical recurrence after radical prostatectomy, which provides a novel potential index for risk stratification and prognostic evaluation of PCa patients.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"800-806"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tonifying kidney and activating blood therapy for the treatment of diabetic erectile dysfunction: A systematic review and meta-analysis]. 补肾活血疗法治疗糖尿病性勃起功能障碍:一项系统综述和荟萃分析。
Q4 Medicine Pub Date : 2025-09-01
Mao-Ke Chen, Ke-Cheng Li, Jun-Long Feng, Xiang-Fa Lin, Wen-Xuan Dong, Zi-Xiang Gao, Hua-Nan Zhang, Hui Chen, Ji-Sheng Wang, Bin Wang

Objective: To systematically evaluate the clinical efficacy and safety of Tonifying kidney and activating blood therapy for the treatment of diabetic mellitus erectile dysfunction. Methods: China National Knowledge Infrastructure(CNKI), Wanfang Data, VIP, Chinese Biomedical Database(CBM), PubMed, Cochrane Library, Embase and Web of Science were searched from inception until October 20th of 2024,for randomized controlled trials of Tonifying kidney and activating blood therapy for the treatment of diabetic erectile dysfunction. Literature screening, quality evaluation, and data extraction were carried out in accordance with relevant standards. The software of RevMan5.4 was used for the analysis of publication bias. And meta-analysis was conducted to assess the impact of this therapy on IIEF-5, total effective rate, adverse reactions. The evidence levels according to the analysis results were evaluated. Results: Totally 19 RCTs were included, involving 1 612 patients. The result of meta-analysis indicated that Tonifying kidney and activating blood therapy had advantages on the improvement of IIEF-5 scores (MD=3.59,95%CI[2.14,5.03],P<0.01),total effective rate (OR=4.30,95%CI[3.29,5.32],P<0.000 01). However, there was no statistically significant difference in the incidence of adverse reactions(OR=0.98,95%CI[0.48,2.01],P=0.96) between the two groups. Conclusions: Tonifying kidney and activating blood therapy can improve the clinical efficacy and IIEF-5 score for the patients with diabetic erectile dysfunction. But considering the limited quantity of included studies, more high-quality studies still be needed to validate the therapeutic effect.

目的:系统评价补肾活血疗法治疗糖尿病性勃起功能障碍的临床疗效和安全性。方法:检索中国知网(CNKI)、万方数据、维普、中国生物医学数据库(CBM)、PubMed、Cochrane图书馆、Embase和Web of Science,检索补肾活血疗法治疗糖尿病性勃起功能障碍的随机对照试验,检索时间为建站至2024年10月20日。按照相关标准进行文献筛选、质量评价和数据提取。采用RevMan5.4软件进行发表偏倚分析。并进行meta分析,评估该疗法对IIEF-5、总有效率、不良反应的影响。根据分析结果对证据水平进行评价。结果:共纳入19项随机对照试验,共纳入1 612例患者。荟萃分析结果显示,补肾活血疗法对改善IIEF-5评分有优势(MD=3.59,95%CI[2.14,5.03],P
{"title":"[Tonifying kidney and activating blood therapy for the treatment of diabetic erectile dysfunction: A systematic review and meta-analysis].","authors":"Mao-Ke Chen, Ke-Cheng Li, Jun-Long Feng, Xiang-Fa Lin, Wen-Xuan Dong, Zi-Xiang Gao, Hua-Nan Zhang, Hui Chen, Ji-Sheng Wang, Bin Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objective: To systematically evaluate the clinical efficacy and safety of Tonifying kidney and activating blood therapy for the treatment of diabetic mellitus erectile dysfunction. Methods: China National Knowledge Infrastructure(CNKI), Wanfang Data, VIP, Chinese Biomedical Database(CBM), PubMed, Cochrane Library, Embase and Web of Science were searched from inception until October 20th of 2024,for randomized controlled trials of Tonifying kidney and activating blood therapy for the treatment of diabetic erectile dysfunction. Literature screening, quality evaluation, and data extraction were carried out in accordance with relevant standards. The software of RevMan5.4 was used for the analysis of publication bias. And meta-analysis was conducted to assess the impact of this therapy on IIEF-5, total effective rate, adverse reactions. The evidence levels according to the analysis results were evaluated. Results: Totally 19 RCTs were included, involving 1 612 patients. The result of meta-analysis indicated that Tonifying kidney and activating blood therapy had advantages on the improvement of IIEF-5 scores (MD=3.59,95%CI[2.14,5.03],P<0.01),total effective rate (OR=4.30,95%CI[3.29,5.32],P<0.000 01). However, there was no statistically significant difference in the incidence of adverse reactions(OR=0.98,95%CI[0.48,2.01],P=0.96) between the two groups. Conclusions: Tonifying kidney and activating blood therapy can improve the clinical efficacy and IIEF-5 score for the patients with diabetic erectile dysfunction. But considering the limited quantity of included studies, more high-quality studies still be needed to validate the therapeutic effect.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"832-840"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Seminal plasma miR-26a-5p influences sperm DNA integrity by targeting and regulating the PTEN gene]. [精浆miR-26a-5p通过靶向和调控PTEN基因影响精子DNA完整性]。
Q4 Medicine Pub Date : 2025-09-01
Chun-Hui Liu, Wen-Sheng Shan, Zhi-Qiang Wang, Shao-Jun Li, Chen Zhu, Hai Wang, Yu-Na Zhou, Rui-Peng Wu

Objective: By analyzing the differential miRNA in seminal plasma between individuals with normal and abnormal sperm DNA fragmentation index(DFI), we aim to identify miRNA that may impact sperm DNA integrity and target genes, and attempt to analyze their potential mechanisms of action.

Methods: A total of 161 study subjects were collected and divided into normal control group, DFI-medium group and DFI-abnormal group based on the DFI detection values. Differential miRNA were identified through miRNA chip analysis. Through bioinformatics analysis and target gene prediction, miRNA related to DFI and specific target genes were identified. The relative expression levels of differential miRNA and target genes in each group were compared to explore the impact of their differential expression on DFI.

Results: Through miRNA chip analysis, a total of 11 differential miRNA were detected. Bioinformatics analysis suggested that miR-26a-5p may be associated with reduced sperm DNA integrity. And gene prediction indicated that PTEN was a specific target gene of miR-26a-5p. Compared to the normal control group, the relative expression levels of miR-26a-5p in both the DFI-medium group and the DFI-abnormal group showed a decrease, while the relative expression levels of PTEN showed an increase. The relative expression levels of miR-26a-5p in all groups were negatively correlated with DFI values, while the relative expression levels of PTEN showed a positive correlation with DFI values in the DFI-medium group and the DFI-abnormal group. The AUC of miR-26a-5p in the DFI-medium group was 0.740 (P<0.05), with a sensitivity of 73.6% and a specificity of 71.5%; the AUC of PTEN was 0.797 (P<0.05), with a sensitivity of 76.5% and a specificity of 78.4%. In the DFI-abnormal group, the AUC of miR-26a-5p was 0.848 (P<0.05), with a sensitivity of 81.3% and a specificity of 78.1%. While the AUC of PTEN was 0.763 (P<0.05), with a sensitivity of 77.2% and a specificity of 80.2%.

Conclusion: miR-26a-5p affects the integrity of sperm DNA by regulating the expression of PTEN negatively. The relative expression levels of seminal plasma miR-26a-5p and PTEN have good diagnostic value for sperm DNA integrity damage, which can help in the etiological diagnosis and prognosis analysis of abnormal DFI. This provides a diagnostic and treatment approach for the study and diagnosis of DFI abnormalities without clear etiology.

目的:通过分析精子DNA片段化指数(DFI)正常与异常个体精浆中miRNA的差异,发现可能影响精子DNA完整性和靶基因的miRNA,并试图分析其潜在的作用机制。方法:选取161例研究对象,根据DFI检测值分为正常对照组、DFI-中等组和DFI-异常组。通过miRNA芯片分析鉴定差异miRNA。通过生物信息学分析和靶基因预测,鉴定出与DFI相关的miRNA和特异性靶基因。比较各组差异miRNA和靶基因的相对表达水平,探讨其差异表达对DFI的影响。结果:通过miRNA芯片分析,共检测到11个差异miRNA。生物信息学分析表明,miR-26a-5p可能与精子DNA完整性降低有关。基因预测表明PTEN是miR-26a-5p的特异性靶基因。与正常对照组相比,dfi培养液组和dfi异常组miR-26a-5p的相对表达水平均下降,而PTEN的相对表达水平升高。各组miR-26a-5p的相对表达量与DFI值呈负相关,而PTEN的相对表达量在DFI中、DFI异常组与DFI值呈正相关。DFI-medium组miR-26a-5p的AUC为0.740 (p)结论:miR-26a-5p通过负向调节PTEN的表达影响精子DNA的完整性。精浆miR-26a-5p和PTEN的相对表达水平对精子DNA完整性损伤有较好的诊断价值,有助于异常DFI的病因诊断和预后分析。这为不明确病因的DFI异常的研究和诊断提供了一种诊断和治疗方法。
{"title":"[Seminal plasma miR-26a-5p influences sperm DNA integrity by targeting and regulating the PTEN gene].","authors":"Chun-Hui Liu, Wen-Sheng Shan, Zhi-Qiang Wang, Shao-Jun Li, Chen Zhu, Hai Wang, Yu-Na Zhou, Rui-Peng Wu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>By analyzing the differential miRNA in seminal plasma between individuals with normal and abnormal sperm DNA fragmentation index(DFI), we aim to identify miRNA that may impact sperm DNA integrity and target genes, and attempt to analyze their potential mechanisms of action.</p><p><strong>Methods: </strong>A total of 161 study subjects were collected and divided into normal control group, DFI-medium group and DFI-abnormal group based on the DFI detection values. Differential miRNA were identified through miRNA chip analysis. Through bioinformatics analysis and target gene prediction, miRNA related to DFI and specific target genes were identified. The relative expression levels of differential miRNA and target genes in each group were compared to explore the impact of their differential expression on DFI.</p><p><strong>Results: </strong>Through miRNA chip analysis, a total of 11 differential miRNA were detected. Bioinformatics analysis suggested that miR-26a-5p may be associated with reduced sperm DNA integrity. And gene prediction indicated that PTEN was a specific target gene of miR-26a-5p. Compared to the normal control group, the relative expression levels of miR-26a-5p in both the DFI-medium group and the DFI-abnormal group showed a decrease, while the relative expression levels of PTEN showed an increase. The relative expression levels of miR-26a-5p in all groups were negatively correlated with DFI values, while the relative expression levels of PTEN showed a positive correlation with DFI values in the DFI-medium group and the DFI-abnormal group. The AUC of miR-26a-5p in the DFI-medium group was 0.740 (P<0.05), with a sensitivity of 73.6% and a specificity of 71.5%; the AUC of PTEN was 0.797 (P<0.05), with a sensitivity of 76.5% and a specificity of 78.4%. In the DFI-abnormal group, the AUC of miR-26a-5p was 0.848 (P<0.05), with a sensitivity of 81.3% and a specificity of 78.1%. While the AUC of PTEN was 0.763 (P<0.05), with a sensitivity of 77.2% and a specificity of 80.2%.</p><p><strong>Conclusion: </strong>miR-26a-5p affects the integrity of sperm DNA by regulating the expression of PTEN negatively. The relative expression levels of seminal plasma miR-26a-5p and PTEN have good diagnostic value for sperm DNA integrity damage, which can help in the etiological diagnosis and prognosis analysis of abnormal DFI. This provides a diagnostic and treatment approach for the study and diagnosis of DFI abnormalities without clear etiology.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"780-790"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on multimodal precision nursing interventions in urinary incontinence rehabilitation management after radical prostatectomy]. [多模式精准护理干预在根治性前列腺切除术后尿失禁康复管理中的研究进展]。
Q4 Medicine Pub Date : 2025-09-01
Ying-Chun Huang, Tong-Tong Zhao, Song Xu, Xue-Jun Shang

Multimodal precision nursing intervention enhances cognitive function and quality of life through multisensory collaborative stimulation by integrating multidimensional data of patients. As one of the most common complications after radical prostatectomy, urinary incontinence seriously affects the quality of life of prostate cancer patients after surgery which has a negative impact on multidimensional health in the "physiological-psychological-social" aspects. This paper summarizes the clinical manifestations, influencing factors, and nursing interventions of urinary incontinence after radical prostatectomy, and focuses on the key points of nursing based on multimodal theory, in order to provide nursing strategies for improving urinary incontinence after prostate cancer surgery.

多模态精准护理干预通过整合患者多维数据,通过多感官协同刺激,提高认知功能和生活质量。尿失禁是根治性前列腺切除术后最常见的并发症之一,严重影响前列腺癌患者术后生活质量,对“生理-心理-社会”多维健康产生负面影响。本文就根治性前列腺切除术后尿失禁的临床表现、影响因素及护理措施进行综述,并结合多模态理论对护理要点进行探讨,以期为改善前列腺癌术后尿失禁提供护理策略。
{"title":"[Research progress on multimodal precision nursing interventions in urinary incontinence rehabilitation management after radical prostatectomy].","authors":"Ying-Chun Huang, Tong-Tong Zhao, Song Xu, Xue-Jun Shang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Multimodal precision nursing intervention enhances cognitive function and quality of life through multisensory collaborative stimulation by integrating multidimensional data of patients. As one of the most common complications after radical prostatectomy, urinary incontinence seriously affects the quality of life of prostate cancer patients after surgery which has a negative impact on multidimensional health in the \"physiological-psychological-social\" aspects. This paper summarizes the clinical manifestations, influencing factors, and nursing interventions of urinary incontinence after radical prostatectomy, and focuses on the key points of nursing based on multimodal theory, in order to provide nursing strategies for improving urinary incontinence after prostate cancer surgery.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"846-850"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expression and function of CDYL-interacting protein MYH9 in mouse testis]. [cdyl相互作用蛋白MYH9在小鼠睾丸中的表达及功能]。
Q4 Medicine Pub Date : 2025-09-01
Huan-Tong Gong, Yan-Mei Quan, Yun-Xia Zhang, Han-Fei Zhu, Xiao-Yu Xia

Objective: To identify the CDYL-interacting proteins in murine testis and investigate the mechanism of CDYL involved in spermatogenesis.

Methods: CDYL-interacting partners in testis were identified using co-immunoprecipitation coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Expression pattern of CDYL-interacting protein MYH9 was analyzed through immunohistochemistry (IHC), confocal immunofluorescence (IF) and Western blot (WB) in mouse testicular cells. The effect of the Cdyl conditional knockout (CdylcKO) in spermatogenic cell on Myh9 expression was quantified via RT-qPCR, WB and IF imaging in both spermatids and spermatozoa from cauda epididymides.

Results: Direct interaction between MYH9 and CDYL was confirmed in murine testis. During spermiogenesis, MYH9 exhibited co-localization with CDYL at the manchette structure, and binding to F-ACTIN, the component of manchette. In cauda epididymal spermatozoa, MYH9 signal concentrated on acrosomal region and continuously distributed along the tail length. Conditional deletion of Cdyl in spermatogenic cell resulted in the transcriptional downregulation of Myh9. In spermatids, CdylcKO led to reduced but retained MYH9 localization to the disorganized manchette structure. In spermatozoa from CdylcKO mice, abnormalities of MYH9 localization were observed, including attenuation of acrosomal signal and/or partial vanishment/enhancement of tail signal.

Conclusion: In murine spermatids, MYH9 protein is localized to the manchette structure, with its expression and subcellular distribution is affected by CDYL protein. CDYL-MYH9 interaction is essential for the spermiogenesis.

目的:鉴定小鼠睾丸中CDYL相互作用蛋白,探讨CDYL参与精子发生的机制。方法:采用免疫共沉淀-液相色谱-串联质谱法(LC-MS/MS)对睾丸中cdyl相互作用的伴侣进行鉴定。采用免疫组化(IHC)、共聚焦免疫荧光(IF)和免疫印迹(WB)分析小鼠睾丸细胞中cdyl相互作用蛋白MYH9的表达模式。通过RT-qPCR、WB和IF成像,定量分析了生精细胞中Cdyl条件敲除(CdylcKO)对Myh9表达的影响。结果:证实MYH9与CDYL在小鼠睾丸中存在直接相互作用。在精子发生过程中,MYH9在manchette结构上与CDYL共定位,并与manchette成分F-ACTIN结合。在附睾尾部精子中,MYH9信号集中在顶体区域,并沿尾长连续分布。生精细胞条件缺失Cdyl导致Myh9转录下调。在精子细胞中,CdylcKO导致MYH9定位减少,但保留在无序的manchette结构中。在CdylcKO小鼠的精子中,观察到MYH9定位异常,包括顶体信号衰减和/或尾部信号部分消失/增强。结论:小鼠精细胞MYH9蛋白定位于manchette结构,其表达和亚细胞分布受CDYL蛋白影响。CDYL-MYH9相互作用对精子发生至关重要。
{"title":"[Expression and function of CDYL-interacting protein MYH9 in mouse testis].","authors":"Huan-Tong Gong, Yan-Mei Quan, Yun-Xia Zhang, Han-Fei Zhu, Xiao-Yu Xia","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To identify the CDYL-interacting proteins in murine testis and investigate the mechanism of CDYL involved in spermatogenesis.</p><p><strong>Methods: </strong>CDYL-interacting partners in testis were identified using co-immunoprecipitation coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Expression pattern of CDYL-interacting protein MYH9 was analyzed through immunohistochemistry (IHC), confocal immunofluorescence (IF) and Western blot (WB) in mouse testicular cells. The effect of the Cdyl conditional knockout (CdylcKO) in spermatogenic cell on Myh9 expression was quantified via RT-qPCR, WB and IF imaging in both spermatids and spermatozoa from cauda epididymides.</p><p><strong>Results: </strong>Direct interaction between MYH9 and CDYL was confirmed in murine testis. During spermiogenesis, MYH9 exhibited co-localization with CDYL at the manchette structure, and binding to F-ACTIN, the component of manchette. In cauda epididymal spermatozoa, MYH9 signal concentrated on acrosomal region and continuously distributed along the tail length. Conditional deletion of Cdyl in spermatogenic cell resulted in the transcriptional downregulation of Myh9. In spermatids, CdylcKO led to reduced but retained MYH9 localization to the disorganized manchette structure. In spermatozoa from CdylcKO mice, abnormalities of MYH9 localization were observed, including attenuation of acrosomal signal and/or partial vanishment/enhancement of tail signal.</p><p><strong>Conclusion: </strong>In murine spermatids, MYH9 protein is localized to the manchette structure, with its expression and subcellular distribution is affected by CDYL protein. CDYL-MYH9 interaction is essential for the spermiogenesis.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 9","pages":"771-779"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华男科学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1